New Treatments for Dry AMD
Age-related macular degeneration (AMD) is the most common form of blindness in the western world and affects individuals over the age of 50. There is currently no treatment for the dry form of the disease. While risk factors for AMD include age, diet and smoking, it is a predominantly genetically driven disease. During this talk, Dr. Clark will provide some background into this devastating eye disease, discuss how the AMD-risk associated mutations affect our immune system and talk about new therapies currently being developed.
Once you have watched the video the 'take the test' button will appear. You must complete and pass the MCQ test to complete the course. Once complete, you can undertake an optional discussion to make this CET interactive.
CET Points: 1
Eyecare credits: 1
Expiry Date: 31/12/2019
Interactive points available
Also accepted by
Dementia: understanding the needs of patients in a clinical setting
This session explores the particular difficulties that people with dementia have with their vision.
Education, Education, Education: when to refer
Eyecare practitioners frequently encounter pathology that requires onward referral either to a colleague or an ophthalmologist.